Huons Global Co Ltd banner
H

Huons Global Co Ltd
KOSDAQ:084110

Watchlist Manager
Huons Global Co Ltd
KOSDAQ:084110
Watchlist
Price: 52 900 KRW -2.22% Market Closed
Market Cap: ₩669.7B

Huons Global Co Ltd
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Huons Global Co Ltd
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
H
Huons Global Co Ltd
KOSDAQ:084110
Research & Development
-₩64.2B
CAGR 3-Years
-6%
CAGR 5-Years
-11%
CAGR 10-Years
-25%
Yuhan Corp
KRX:000100
Research & Development
-₩197B
CAGR 3-Years
-19%
CAGR 5-Years
-10%
CAGR 10-Years
-19%
SK Biopharmaceuticals Co Ltd
KRX:326030
Research & Development
-₩162.2B
CAGR 3-Years
-12%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Research & Development
-₩189.1B
CAGR 3-Years
-9%
CAGR 5-Years
4%
CAGR 10-Years
-1%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Research & Development
-₩8.7B
CAGR 3-Years
-8%
CAGR 5-Years
17%
CAGR 10-Years
-9%
C
Caregen Co Ltd
KOSDAQ:214370
Research & Development
-₩5.7B
CAGR 3-Years
3%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
No Stocks Found

Huons Global Co Ltd
Glance View

Market Cap
669.7B KRW
Industry
Pharmaceuticals

Huons Global Co., Ltd. engages in the management of its subsidiaries and provision of botulinum toxin. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2006-12-19. Along with its subsidiaries, the Company operates its business through two segments: pharmaceutical segment and glass container segment. The pharmaceutical segment produces pharmaceutical products including parenteral injections such as lidocaines, merit C injections; tablets such as phentermines, diet pills and others; capsules such as Daisen and Fuxetine and other ethical and over-the-counter drugs. The glass container segment produces ampoules, vials, cartridges and caps for used of medicals, foods and cosmetics. The firm also manufactures medical devices such as kits, derma injectors and other injector.

Intrinsic Value
38 033.3 KRW
Overvaluation 28%
Intrinsic Value
Price
H

See Also

What is Huons Global Co Ltd's Research & Development?
Research & Development
-64.2B KRW

Based on the financial report for Sep 30, 2025, Huons Global Co Ltd's Research & Development amounts to -64.2B KRW.

What is Huons Global Co Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
-25%

Over the last year, the Research & Development growth was 7%. The average annual Research & Development growth rates for Huons Global Co Ltd have been -6% over the past three years , -11% over the past five years , and -25% over the past ten years .

Back to Top